A052101
OPEN TO ACCRUAL
Ph 3 Study of Continuous v Intermittent Zanubrutinib Maintenance Therapy in Older Patients with MCL
S2114
OPEN TO ACCRUAL
Ph II Trial of Consolidation Tx Following CD19 CAR T Tx for Relapse/Refractory DLBCL or Gr IIIB FL
UW19086
OPEN TO ACCRUAL
LTFU Protocol for Subjects Treated with Gene-Modified T Cells
UW20062
OPEN TO ACCRUAL
Metabolic Profiling of Leukemic Cells through Isotope Tracing in Patients with CLL
UW22057
OPEN TO ACCRUAL
Single Arm Ph I/II Study of Tazemetostat with Rituximab and Abbrev Bendamustine in Tx of HTBFL
UW22069
OPEN TO ACCRUAL
PH 2 Study MK-2140 in pts with Aggressive and Indolent B-Cell Malignancies
UW22087
OPEN TO ACCRUAL
Phase II Study of Venetoclax-Obinutuzumab Retreatment in Patients with Recurring CLL
UW23058
OPEN TO ACCRUAL
Phase 3 Study of Nemtabrutinib Plus Venetoclax vs VR in 2L+ R/R CLL/SLL